We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current MDMXF market cap is 717.97M. The company's latest EPS is CHF 0.0170 and P/E is 1023.53.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Total Revenue | 420.7M | 351.3M | 457.3M | 477.1M | 486.6M |
| Operating Income | 38.2M | 18M | 59.9M | 19.5M | 16M |
| Net Income | 25.2M | 9.6M | 44M | 11.6M | 700k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Total Assets | 697M | 789.9M | 974.4M | 1.11B | 1.01B |
| Total Liabilities | 401.9M | 456.5M | 440.5M | 601.1M | 532.5M |
| Total Equity | 295.1M | 333.4M | 533.9M | 504.8M | 474.3M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Operating | 89.1M | 50.6M | 87.3M | 47.6M | 56.1M |
| Investing | -39.6M | 4.4M | -3.3M | -57M | -80.6M |
| Financing | -59M | -42.9M | 111.6M | 116M | -153.8M |
| Market Cap | 717.97M |
| Price to Earnings Ratio | 1023.53 |
| Price to Sales Ratio | 1.48 |
| Price to Cash Ratio | 5.5 |
| Price to Book Ratio | 1.51 |
| Dividend Yield | - |
| Shares Outstanding | 41.26M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -36.47% |
| 52 Week High | 27.39 |
| 52 Week Low | 16.05 |
| Spread (Intraday) | 2.1 (11.26%) |
| Company Name | Medmix Ag Namen Akt Switzerland (PK) |
| Address |
dammstrasse 19 zug 6300 |
| Website | https://www.medmix.swiss |
| Industry | health & allied services,nec (8099) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
